Bemiparin as a thromboprophylaxis after gynaecological surgeries
What is it about?
Bemiparin is a second generation low molecular heparin which differ from the first generation low molecular weight heparin regarding the mode of action . It was an effective thromboprophylactic drug after it use following benign gynecological surgeries
Why is it important?
This clinical trial is regarded the first to be conducted after benign gynecological surgeries and with a large sample size
The following have contributed to this page: Professor Shahla kreem Alalaf
In partnership with: